Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allpeptide is a biotechnology company based in Hangzhou, China, specializing in the research, development, and large-scale production of peptides and their derivatives. The company operates as a Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO), providing custom peptide synthesis, catalog peptides, and complex modifications such as isotope labeling, PEGylation, and peptide-drug conjugates (PDC). Allpeptide maintains a significant R&D center and multiple production facilities equipped with advanced synthesis and purification technologies, including microwave-assisted synthesis and high-performance liquid chromatography (HPLC). Their services support a global clientele across the pharmaceutical, cosmetic, and life sciences industries, facilitating drug discovery and diagnostic development. The company is recognized for its expertise in producing high-purity peptides and handling diverse, complex sequences for both research and commercial applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allpeptide.